CTI BioPharma (United Kingdom)

Institution (Company)

Homepage ROR

Also Known As

CTI BioPharma (United Kingdom), Cell Therapeutics

256

Publications

43.6K

Citations

Authors

225

Concepts

About

CTI BioPharma (United Kingdom) is a company institution in London, United Kingdom known for medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	134	26.9K
2	Engineering	10	22	757
3	Natural Sciences	10	22	1.6K
4	Public Health	3	3	156
5	Health Sciences	2	5	112

CTI BioPharma (United Kingdom)

256

Publications

43.6K

Citations

Page 1

	Year	Citations
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy Christine E. Brown, Darya Alizadeh, Renate Starr, New England Journal of Medicine Cell TherapyImmunologyImmune RegulationImmunotherapeuticsHigh-grade Gliomas	2016	1.8K
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product Helene M. Finney, Alastair D. G. Lawson, Christopher Bebbington, The Journal of Immunology	1998	532
Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM Francis Ofei, Steve Hurel, José Newkirk, Diabetes	1996	510
Membrane‐Type Matrix Metalloproteinases 1 and 2 Exhibit Broad‐Spectrum Proteolytic Capacities Comparable to Many Matrix Metalloproteinases Marie‐Pia d’Ortho, Horst Will, Susan J. Atkinson, European Journal of Biochemistry	1997	437
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) Patrick Hayden, Claire Roddie, Peter Bader, Annals of Oncology	2021	389
Therapeutic antibody fragments with prolonged in vivo half-lives Andrew P. Chapman, Pari Antoniw, Mariangela Spitali, Nature Biotechnology Immunocytochemical TechniqueImmunologyAntibody ScreeningTherapeutic Antibody FragmentsAntibody Engineering	1999	347
An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial William J. Sandborn, Brian G. Feagan, S. B. Hanauer, Gastroenterology InflammationMucosal ImmunologyMedicineImmunologyPathology	2001	252
Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells Simeon Santourlidis, Hans‐Ingo Trompeter, Sandra Weinhold, The Journal of Immunology	2002	243
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity Dongrui Wang, Brenda Aguilar, Renate Starr, JCI Insight	2018	223
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients Johannes Fischer, Dieter Niederacher, Stefan A. Topp, Proceedings of the National Academy of Sciences	2013	221

Page 1